As well as fundraising for our charity partners, we offer meeting room space, operational support, governance and strategy advice and volunteering time.
This year, our Charity of the Year is The Royal Marsden Cancer Charity. Macfarlanes is supporting The Royal Marsden’s groundbreaking Cancer Immunotherapy Research Project, in part inspired by the experience of one of our firm's partners who underwent life-saving immunotherapy treatment at The Royal Marsden. Immunotherapy boosts the body’s own immune system to recognise and attack cancer cells and has led to the development of new drugs which now offer hope to patients with advanced and previously untreatable cancer. This Cancer Immunotherapy Research Project is being led by world-leading oncologists Professor James Larkin, Dr Samra Turajlic and Professor Martin Gore and developing this new area of treatment holds huge potential for cancer patients worldwide.
Recent Charities of the Year were:
- 2017-2018 – Place2Be
- 2016-2017 – Brain Tumour Charity
- 2015-2016 – Whizz Kidz
- 2014-2015 – Prostate Cancer
- 2013-2014 – St Mungo's
- 2012-2013 – Richard House Children's Hospice
Throughout the annual campaign, a diverse range of fundraising events are organised across the firm including quiz nights, bake sales, film screenings, concerts by our firm choir and a huge Christmas raffle, as well as members of staff taking part in established sporting events such as the London Marathon in aid of the charity.
To increase these donations further, the firm also offers a matched giving scheme for staff fundraising for the Charity of the Year. We also run an annual Happy Hour appeal, which enables staff to donate one hour of their salary. The firm matches the total sum raised from this appeal.
Another exciting new fundraising initiative coincides with the opening of our new building and integrated new coffee house. The firm has agreed that for each hot drink purchased in the Department of Coffee and Social Affairs coffee bar, 50p will be donated to the Charity of the Year.
We are delighted to be supporting The Royal Marsden Cancer Charity, funding their innovative Cancer Immunotherapy Research Project. 72% of our staff voted and The Royal Marsden Cancer Charity received 44% of the vote.